183 related articles for article (PubMed ID: 35676015)
1. Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study.
Shoji F; Yamashita T; Kinoshita F; Takamori S; Fujishita T; Toyozawa R; Ito K; Yamazaki K; Nakashima N; Okamoto T
BMJ Open; 2022 Jun; 12(6):e061674. PubMed ID: 35676015
[TBL] [Abstract][Full Text] [Related]
2. Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Shoji F; Miura N; Tagawa T; Tsukamoto S; Okamoto T; Yamazaki K; Hamatake M; Takeo S
Thorac Cancer; 2022 Oct; 13(19):2829-2833. PubMed ID: 36063818
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study.
Watanabe K; Yoh K; Hosomi Y; Usui K; Naka G; Kishi K; Uemura K; Ohashi Y; Kunitoh H
BMJ Open; 2022 Jan; 12(1):e046451. PubMed ID: 34983748
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study.
Sakamaki K; Watanabe K; Woo T; Masuda M
BMJ Open; 2020 Nov; 10(11):e040969. PubMed ID: 33257489
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).
Veziant J; Poirot K; Chevarin C; Cassagnes L; Sauvanet P; Chassaing B; Robin F; Godfraind C; Barnich N; Pezet D; Pereira B; Gagniere J; Bonnet M
BMJ Open; 2020 Jan; 10(1):e031472. PubMed ID: 31915159
[TBL] [Abstract][Full Text] [Related]
7. Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.
Chau J; Yadav M; Liu B; Furqan M; Dai Q; Shahi S; Gupta A; Mercer KN; Eastman E; Hejleh TA; Chan C; Weiner GJ; Cherwin C; Lee STM; Zhong C; Mangalam A; Zhang J
BMC Cancer; 2021 Jul; 21(1):808. PubMed ID: 34256732
[TBL] [Abstract][Full Text] [Related]
8. Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study.
Vinke PC; Combalia M; de Bock GH; Leyrat C; Spanjaart AM; Dalle S; Gomes da Silva M; Fouda Essongue A; Rabier A; Pannard M; Jalali MS; Elgammal A; Papazoglou M; Hacid MS; Rioufol C; Kersten MJ; van Oijen MG; Suazo-Zepeda E; Malhotra A; Coquery E; Anota A; Preau M; Fauvernier M; Coz E; Puig S; Maucort-Boulch D
BMJ Open; 2023 Apr; 13(4):e069090. PubMed ID: 37105689
[TBL] [Abstract][Full Text] [Related]
9. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.
Duttagupta S; Hakozaki T; Routy B; Messaoudene M
Curr Oncol; 2023 Oct; 30(11):9406-9427. PubMed ID: 37999101
[TBL] [Abstract][Full Text] [Related]
10. Assessment of aflatoxin exposure, growth faltering and the gut microbiome among children in rural Guatemala: protocol for an observational prospective cohort and bioreactor simulations.
Cheng Q; Glesener H; Montenegro G; Torres O; Miller AC; Krajmalnik-Brown R; Rohloff P; Voth-Gaeddert LE
BMJ Paediatr Open; 2023 Apr; 7(1):. PubMed ID: 37080609
[TBL] [Abstract][Full Text] [Related]
11. Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients.
Song P; Yang D; Wang H; Cui X; Si X; Zhang X; Zhang L
Thorac Cancer; 2020 Jun; 11(6):1621-1632. PubMed ID: 32329229
[TBL] [Abstract][Full Text] [Related]
12. Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol.
Bieri U; Scharl M; Sigg S; Szczerba BM; Morsy Y; Rüschoff JH; Schraml PH; Krauthammer M; Hefermehl LJ; Eberli D; Poyet C
BMJ Open; 2022 Apr; 12(4):e061421. PubMed ID: 35437256
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial.
Bingula R; Filaire M; Radosevic-Robin N; Berthon JY; Bernalier-Donadille A; Vasson MP; Thivat E; Kwiatkowski F; Filaire E
Medicine (Baltimore); 2018 Dec; 97(50):e13676. PubMed ID: 30558074
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study.
Jiménez-Jorge S; Labrador-Herrera G; Rosso-Fernández CM; Rodríguez-Torres N; Pachón-Ibáñez ME; Smani Y; Márquez-Malaver FJ; Limón Ramos C; Solano C; Vázquez-López L; Kwon M; Mora Barrios JM; Aguilar-Guisado M; Espigado I;
BMJ Open; 2020 Jul; 10(7):e034570. PubMed ID: 32690735
[TBL] [Abstract][Full Text] [Related]
16. Protocol for the ASTRO study (SSOP-01): a multicentre prospective cohort study investigating adverse events based on electronic patient-reported outcomes in patients with breast cancer after adjuvant chemotherapy.
Kuniyoshi O; Sano M; Nakano Y; Kawaguchi T; Hatakeyama T; Tsuchiya Y; Inada Y; Harada T; Kurosaki M; Mashiko T; Miyaji T; Yamaguchi T
BMJ Open; 2023 Sep; 13(9):e071500. PubMed ID: 37709306
[TBL] [Abstract][Full Text] [Related]
17. The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease.
Khan F; Stewart I; Howard L; McKeever TM; Jones S; Hearson G; Braybrooke R; Edwards C; Jenkins G; Saini G
BMJ Open Respir Res; 2019; 6(1):e000439. PubMed ID: 31258922
[TBL] [Abstract][Full Text] [Related]
18. BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.
Kasi PM; Chakrabarti S; Sawyer S; Krainock M; Poklepovic A; Ansstas G; Maninder M; Malhotra M; Ensor J; Gao L; Eroglu Z; Ellers S; Billings P; Rodriguez A; Aleshin A
BMJ Open; 2022 May; 12(5):e060342. PubMed ID: 35636789
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and prognosis of non-small cell lung cancer patients who underwent curable surgery: a protocol for a real-world, retrospective, population-based and nationwide Chinese National Lung Cancer Cohort (CNLCC) study.
Wang X; Liang Y; Wang Y; Meng X; Zhou B; Xu Z; Wang H; Yang W; Li N; Gao Y; He J;
BMJ Open; 2023 Jun; 13(6):e070188. PubMed ID: 37380208
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study.
Deng Y; Hu H; Jia R; Dai W; Wang D; Zhang P; Zhang P; Cheng K; Tang J; Wen Y; Zhou X; Shi Q; Xiong Z; Zhou J
BMC Pulm Med; 2023 May; 23(1):176. PubMed ID: 37208661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
